文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

基于肠道菌群失调与细菌移位建立并评价新型持续性炎症、免疫抑制和分解代谢综合征动物模型

Establishment and Evaluation of a New Type of Animal Model of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome Based on Gut Microbiota Dysbiosis and Bacterial Translocation.
PubMed 文献 · Shock · 2025-04-30
一句话结论基于改良盲肠结扎穿孔联合地塞米松的小鼠模型可再现持续性炎症、免疫抑制和分解代谢综合征(PICS)特征,细菌移位在其中起关键作用。

研究将8-10周龄C57BL/6雄性小鼠分为假手术组、地塞米松(DEXA)组、盲肠结扎穿孔(CLP)组和CLP+DEXA组,每组10只;第1天用改良CLP诱导脓毒症(盲肠结扎点距盲肠末端30%),第3天起注射地塞米松2 mg/kg/天维持炎症反应。第14天CLP+DEXA组IL-6、TNF-α、IL-1β较CLP组分别升高约3000%、400%、300%,MDSC比例约31.2%、CD4+T细胞约5.7%(CLP组分别为22.97%和8.03%),体重和肌肉量分别减少约3.6 g和135 mg,Atrogin-1和MuRF-1表达升高超过500%,肠紧密连接蛋白ZO-1和Occludin严重破坏,16S rRNA和血平板证实肠道菌群失调与细菌移位。作者据此建立新型小鼠PICS模型,认为细菌移位在PICS中起关键作用,并提示色氨酸衍生物可能成为治疗靶点。

要点

  • 模型构建:8-10周龄C57BL/6雄性小鼠,第1天行改良CLP(结扎点距盲肠末端30%),第3天起地塞米松2 mg/kg/天注射以维持炎症。
  • 第14天CLP+DEXA组IL-6、TNF-α、IL-1β较CLP组分别升高约3000%、400%、300%。
  • CLP+DEXA组MDSC比例约31.2%、CD4+T细胞约5.7%,CLP组分别为22.97%和8.03%,提示严重免疫抑制。
  • CLP+DEXA组体重和肌肉量较CLP组分别减少约3.6 g和135 mg,Atrogin-1和MuRF-1表达升高超过500%。
  • CLP+DEXA小鼠肠紧密连接蛋白ZO-1和Occludin严重破坏,16S rRNA和血平板证实菌群失调与细菌移位。

适用人群与场景

  • 8-10周龄C57BL/6雄性小鼠,每组10只,分为假手术组、地塞米松组、CLP组和CLP+DEXA组。

处置流程与药物剂量

  • 第1天采用改良盲肠结扎穿孔术诱导脓毒症,结扎点位于距盲肠末端30%处。
  • 第3天起注射地塞米松2 mg/kg/天以维持炎症反应。
  • 第14天采用ELISA、流式细胞术、蛋白质印迹和Q-PCR检测炎症、免疫抑制和分解代谢指标。

研究设计与关键结果

  • 动物实验:每组10只C57BL/6雄性小鼠,比较假手术、地塞米松、CLP和CLP+DEXA四组。
  • 第14天CLP+DEXA组IL-6、TNF-α、IL-1β较CLP组分别升高约3000%、400%、300%。
  • CLP+DEXA组MDSC比例约31.2%、CD4+T细胞约5.7%,CLP组分别为22.97%和8.03%。
  • CLP+DEXA组体重和肌肉量较CLP组分别减少约3.6 g和135 mg,Atrogin-1和MuRF-1表达升高超过500%。
  • CLP+DEXA小鼠肠紧密连接蛋白ZO-1和Occludin严重破坏,16S rRNA和血平板证实菌群失调与细菌移位。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型建立与评价)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为细菌移位在PICS中起关键作用,并提示色氨酸衍生物可能作为PICS的潜在治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) refers to the chronic critical illness phase of severe immunosuppression with persistent inflammatory response and repeated nosocomial infections, protein hypercatabolism, poor nutritional status, and persistent multiple organ injury in critical patients. These patients are difficult to treat and have a poor prognosis. Here, we established a new type of mouse PICS model to investigate its underlying pathophysiological mechanisms and its potential treatment.

METHODS: We divided C57BL/6 male mice at 8-10 weeks into SHAM-operated group, DEXA group, CLP group and CLP + DEXA group. Each group had 10 mice. Sepsis was induced using a modified cecal ligation and perforation (CLP) model on day 1 (cecal ligation site to 30% away from the end of the cecal), and the inflammatory response was maintained by injection of dexamethasone (DEXA) at a dose of 2 mg/kg/day on day 3. Then ELISA, flow cytometry, western blotting and Q-PCR were used to detect inflammation, immunosuppression and catabolic indicators in mice.

RESULTS: We found that at day 14, the levels of IL-6, TNF-α, and IL-1β in the CLP + DEXA group increased by approximately 3,000%, 400%, and 300%, respectively, compared to the CLP group. The proportions of MDSCs and CD4 + T cells in the CLP + DEXA group were about 31.2% and 5.7%, while the proportions in the CLP group were 22.97% and 8.03%. This result also suggests a severe immunosuppressive state in the CLP + DEXA group. Compared with the CLP group, the body weight and muscle mass of the CLP + DEXA group were reduced by about 3.6 g and 135 mg, respectively, and the expression of muscle atrophy related genes such as Atrogin-1 and MuRF-1 was also increased by more than 500%. By examining intestinal tight junction proteins such as ZO-1 and Occludin, we found that the intestinal barrier of CLP + DEXA mice was severely disrupted. The 16srRNA and blood coated plates also confirmed the presence of the gut microbiota dysbiosis and translocation in the CLP + DEXA mice, which was similar to those in critically ill patients.

CONCLUSIONS: Collectively, our work developed a new type of mouse PICS model and elucidated that bacterial translocation plays a critical role in PICS. It also sheds light on tryptophan derivatives as potential therapeutic targeting of PICS.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang K, Zhang X, Xie T, et al. Establishment and Evaluation of a New Type of Animal Model of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome Based on Gut Microbiota Dysbiosis and Bacterial Translocation. Shock. 2025. PMID: 40341508. doi:10.1097/SHK.0000000000002621

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。